By Stewart Eisenhart, Emergo Group
The China Food and Drug Administration (CFDA) appears to have stopped charging substantial fees for in-country registration testing of medical devices.
Get the full story here at the Emergo Group’s blog.
The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MedicalDesignandOutsourcing.com or its employees.